Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Think.Health

Investor type Venture Capital
Founders Dr. Florian Kainzinger

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 30
Average round size
info
The average size of a deal this fund participated in
$7M
Portfolio companies 18
Rounds per year 2.00
Lead investments 9
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.40
Exits 3
Key employees 2
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Health Care
  • mHealth
  • Health Diagnostics
  • Biotechnology
  • Medical Device
Summary

The company was established in Europe in Germany. The main department of described VC is located in the Fu00fcrstenfeldbruck.

Speaking about the real fund results, this VC is 40 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 5 - 10 millions dollars. The high activity for fund was in 2018. This Think.Health works on 16 percentage points less the average amount of lead investments comparing to the other organizations. The fund is constantly included in 2-6 investment rounds annually.

The current fund was established by Dr. Florian Kainzinger.

The typical case for the fund is to invest in rounds with 2 participants. Despite the Think.Health, startups are often financed by Keiretsu Capital, High-Tech Gru00fcnderfonds, about:seed GmbH. The meaningful sponsors for the fund in investment in the same round are Atlantic Labs, Northpond Ventures, High-Tech Gru00fcnderfonds. In the next rounds fund is usually obtained by EASME - EU Executive Agency for SMEs, SpinLab - The HHL Accelerator, Northpond Ventures.

Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most successful fund investment fields, there are Internet, Fitness. Among the most popular portfolio startups of the fund, we may highlight Caspar Health, PreOmics, First Light Diagnostics. The fund has specific favorite in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Germany.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Think.Health:
Typical Co-investors
Think.Health is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Think.Health:

Funds with similar focus

Funds from Germany
Funds with similar focus located in Germany:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Accel X Central, Central Region, Singapore
Belcube Belgium, Brussels, Brussels Hoofdstedelijk Gewest
Gary Community Investments Colorado, Denver, United States
Good Technology California, Sunnyvale, United States
Hitachi Ventures Bayern, Germany, München
Huawei Technologies China, Guangdong, Shenzhen
Incutex Company Builders Argentina, Córdoba, Cordoba
INROADS Capital Partners Evanston, Illinois, United States
JNKS Investments -
Kington Capital China, Jiangsu, Suzhou
McDonald Partners Cleveland, Ohio, United States
MetaStable Capital California, San Francisco, United States
PlayFast Games -
Resources Connection California, Costa Mesa, United States
Rhon-Klinikum Bad Neustadt An Der Saale, Bavaria, Germany
Rongta Ziben China, Guangxi, Jiangsu
Serena Ventures California, San Francisco, United States
Vilitas GmbH & Co. KG Aachen, Germany, Nordrhein-Westfalen
WSR Capital Colorado, Highlands Ranch, United States
Zencoder California, San Francisco, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Navignostics AG

Bioinformatics
Biotechnology
Health Care
Health Diagnostics
Life Science
Medical
Medical Device
Personal Health
$8M09 Nov 2022 Zürich, Zurich, Switzerland

Vara

Artificial Intelligence
Health Care
Health Diagnostics
Machine Learning
$5M25 Oct 2022 Berlin, Berlin, Germany

anvajo

Biotechnology
Life Science
Manufacturing
Medical Device
Veterinary
$20M19 Oct 2022 Dresden, Sachsen, Germany

Big Data
Bioinformatics
Biotechnology
Health Care
Health Diagnostics
$102M16 Mar 2021 California, United States

Myo

Health Care
Hospitality
Nursing and Residential Care
$3M25 Oct 2020 Berlin, Berlin, Germany

Vara

Artificial Intelligence
Health Care
Health Diagnostics
Machine Learning
$7M02 Jun 2020 Berlin, Berlin, Germany

SpinDiag

Health Care
Medical
Medical Device
$19M26 May 2020 Freiburg im Breisgau, Baden-Württemberg, Germany

Endodont

Health Care
Medical Device
07 May 2020 Berlin, Berlin, Germany

Selfapy

Fitness
Health Care
Wellness
$7M04 Feb 2020 Berlin, Berlin, Germany
News
Inflammatix Secures $102 Million in Series D Financing Led by D1 Capital Partners to Commercialize Novel Host Response Diagnostics

– Inflammatix, a pioneering molecular diagnostics company, announced today the closing of a $102m Series D round of financing to support development and commercialization of its novel immune response diagnostics portfolio.
D1 Capital Partners led the round, with participation from the company’s existing investors, including Northpond Ventures, Khosla Ventures, Think.Health, and OSF Healthcare Ventures.
– Sepsis caused more than five million deaths annually worldwide before the COVID-19 pandemic, and severe COVID-19 has been recognized as viral sepsis. In addition, antibiotic resistance is directly responsible for more than 700,000 deaths annually worldwide.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Think.Health?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: